More Company News

Scancell

COVIDITY Phase 1 CTA in South Africa approved
29 Jul 2021Read More

Scancell

Professor Lindy Durrant appointed CEO
28 Jul 2021Read More

Scancell

COVIDITY Phase I trial planned in South Africa and UK
22 Jun 2021Read More

Scancell

Update on SCIB2 clinical development partnership
03 Feb 2021Read More

Scancell

Interim results for six months ended 31 October 2020
29 Jan 2021Read More

Scancell

COVID-19 vaccine candidate selected
18 Dec 2020Read More

Scancell

Appointment of CMO and Medical Director
17 Nov 2020Read More

Scancell

Result of adjourned General Meeting
05 Nov 2020Read More

Scancell

Conversion of CLNs and total voting rights
02 Nov 2020Read More

Scancell

Result of open offer and adjournment of General Meeting
29 Oct 2020Read More

1 2 3 4 5
Return to Scancell
© 2019-21 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).